Dr. Adrian Percy, former head of R&D for the Crop Science Division of Bayer, recently joined Finistere Ventures as Chief Technology Officer. Percy will provide strategic, technical and regulatory guidance for current portfolio companies. He will also support Finistere’s continued investment efforts, working with the team to identify and evaluate potential opportunities.
Percy is pictured with Arama Kukutai, co-founder and partner at Finistere Ventures.
As part of the appointment, he will be joining the Boards of two Finistere-backed companies, BioLumic and Hi Fidelity Genetics (also based in Research Triangle), and will play a pivotal role in helping shape their ongoing research and development strategies, as well as supporting their partnership and commercialization efforts.
Audio – Interview with Dr. Adrian Percy